Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceuticals in river- and drinking-water of the Madrid Region in Spain

Chemosphere

Volumn 82, Issue 7, 2011, Pages 1062-1071

  Valcarcel Y ^a   Alonso, S González ^a   Rodriguez Gil J L ^b   Maroto, R Romo ^a   Gil, A ^a   Catala M ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Analgesic anti inflammatory antipyretic; Cardiovascular; Pharmaceuticals; Sewage treatment plant; Spain; Surface water

Indexed keywords

BIOACTIVITY; DISEASES; DRUG PRODUCTS; EFFLUENTS; POTABLE WATER; RIVERS; SURFACE WATERS; WASTEWATER DISPOSAL;

ANALGESIC/ANTI-INFLAMMATORY/ANTIPYRETIC; BIOLOGICALLY ACTIVE COMPOUNDS; CARDIO-VASCULAR DISEASE; CARDIOVASCULAR; ECOTOXICOLOGICAL EFFECTS; ENVIRONMENTAL SURVEILLANCE; SEWAGE TREATMENT PROCESS; SPAIN;

SEWAGE TREATMENT PLANTS;

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; ATENOLOL; CARDIOVASCULAR AGENT; DICLOFENAC; DRINKING WATER; FUROSEMIDE; GEMFIBROZIL; HYDROCHLOROTHIAZIDE; IBUPROFEN; NAPROXEN; RIVER WATER; SURFACE WATER;

CARDIOVASCULAR DISEASE; DRINKING WATER; DRUG; EFFLUENT; NEIGHBORHOOD; SEWAGE TREATMENT; SURFACE WATER; WASTE DISPOSAL; WATER POLLUTION;

ARTICLE; CONCENTRATION (PARAMETERS); ECOTOXICOLOGY; EFFLUENT; ENVIRONMENTAL MONITORING; PRESCRIPTION; SEWAGE TREATMENT; SEWAGE TREATMENT PLANT; SPAIN; WATER CONTAMINATION; WATER POLLUTANT; WATER SAMPLING;

MADRID [SPAIN]; SPAIN;

EID: 78651424399     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2010.10.041     Document Type: Article

References (50)

1. Alder A.C., Schaffner C., Majewsky M., Klasmeier J., Fenner K. Fate of beta-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Res. 2010, 44:936-948.
2. Alonso R., Mata N., Mata P. Control de las hiperelipemias en la práctica clínica. Revista Española de Cardiología 2006, 6:24-35.
3. Antoñanzas F., Rodríguez R., Sacristán J., Illa R. Los medicamentos en la Unión Europea: el tándem comercio-salud. Gaceta Sanitaria 2005, 19:1-16.
4. Bendz D., Paxeus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard. Mater. 2005, 122:195-204.
5. Calamari D., Zuccato E., Castiglioni S., Bagnati R., Fanelli R. Strategic survey of therapeutic drugs in the rives Po and Lambro in northern Italy. Environ. Sci. Technol. 2003, 37:1241-1248.
6. Carballa M., Omil F., Lema J.M., Llompart M., Garcia C., Rodriguez I., Gomez M., Ternes T. Behaviour of pharmaceuticals and personal care products in a sewage treatment plant of northwest Spain. Water Sci. Technol. 2005, 52:29-35.
7. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72:1118-1123.
8. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40:357-363.
9. Derksen J.G., Rijs G.B., Jongbloed R.H. Diffuse pollution of surface water by pharmaceutical products. Water Sci. Technol. 2004, 49:213-221.
10. Farmaindustria. La industria farmacéutica en cifras. <> (accessed February 2010). http://www.farmaindustria.es/idc/groups/public/documents/publicaciones/farma_002843.pdf.
11. Farre M.L., Ferrer I., Ginebreda A., Figueras M., Olivella L., Tirapu L., Vilanova M., Barcelo D. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J. Chromatogr. A 2001, 938:187-197.
12. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
13. Fortuny J., Silverman D., Malats N., Tardón A., García R., Serra C., Carrato A., Rothman N., Dosemeci M., Kogevinas M. Uso de analgésicos y ácido acetilsalicílico en un estudio multicéntrico en España. Gaceta Sanitaria 2005, 19:316-320.
14. García del Pozo J., Ramos Sevilano E., De Abajo F., Mateos Campos R. Utilización de los antihipertensivos en España (1995-2001). Revista Española de Cardiología 2004, 57:241-249.
15. Garner S.S., Wiest D.B., Reynolds E.R. Stability of atenolol in an extemporaneously compounded oral liquid. Am. J. Hosp. Pharm. 1994, 51:508-511.
16. Glassmeyer S.T., Hinchey E.K., Boehme S.E., Daughton C.G., Ruhoy I.S., Conerly O., Daniels R.L., Lauer L., McCarthy M., Nettesheim T.G., Sykes K., Thompson V.G. Disposal practices for unwanted residential medications in the United States. Environ. Int. 2009, 35:566-572.
17. González Alonso S., Catalá M., Romo R., Rodríguez J., Gil A., Valcárcel Y. Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan Area (Spain). Environ. Int. 2010, 36:195-210.
18. Gros M., Petrovic M., Barcelo D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (northeast Spain). Environ. Toxicol. Chem. 2007, 26:1553-1562.
19. Gros M., Petrovic M., Barcelo D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal. Chem. 2009, 81:898-912.
20. Gros M., Petrovic M., Ginebreda A., Barcelo D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36:15-26.
21. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
22. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 2002, 43:229-235.
23. Hummel D., Loffler D., Fink G., Ternes T.A. Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ. Sci. Technol. 2006, 40:7321-7328.
24. IMS Health, 2006. IMS Health Service Team. Available from: <> (accessed February 2010). http://www.imshealth.com.
25. INEbase, 2007. National Statistics Institute on-line database. <> (accessed February 2010). http://www.ine.es/inebmenu/indice.htm.
26. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res. 2008, 42:3498-3518.
27. Khetan S.K., Collins T.J. Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry. Chem. Rev. 2007, 107:2319-2364.
28. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
29. Kümmerer K. Pharmaceuticals in the environment: scope of the vook and introduction. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks 2004, 3-12. Springer, Heidelberg, Germany.
30. Martinez Bueno M., Hernando M., Herrera S., Gómez M., Fernández-Alba A., Bustamante I., García-Calvo E. Pilot survey of chemical contaminants from industrial and human activities in river waters in Spain. Int. J. Environ. Anal. Chem. 2010, 90:321-343.
31. Mompelat S., Le B.B., Thomas O. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ. Int. 2009, 35:803-814.
32. Pailler J.Y., Krein A., Pfister L., Hoffmann L., Guignard C. Solid phase extraction coupled to liquid chromatography-tandem mass spectrometry analysis of sulfonamides, tetracyclines, analgesics and hormones in surface water and wastewater in Luxembourg. Sci. Total Environ. 2009, 407:4736-4743.
33. Petrovic M., Hernando M.D., Díaz-Cruz M.S., Barcelo D. Liquid chromatography-tandem mass spectrometry for the analysis of pharmaceutical residues in environmental samples: a review. J. Chromatogr. A 2005, 1067:1-14.
34. Pomati F., Castiglioni S., Zuccato E., Fanelli R., Vigetti D., Rossetti C., Calamari D. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ. Sci. Technol. 2006, 40:2442-2447.
35. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43:831-841.
36. Richardson M.L., Bowron J.M. The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol. 1985, 37:1-12.
37. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356:143-153.
38. Sans S., Paluzie G., Puig T., Balaña L., Balaguer-Vintró I. Prevalencia del consumo de medicamentos en la población adulta de Cataluña. Gaceta Sanitaria 2002, 16:121-130.
39. Spanish Society of Cardiology, 2009. Sociedad Española de Cardiología Available from: <> (accessed February 2010). http://secardiologia.es.
40. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 1999, 225:135-141.
41. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
42. Ternes T. Analytical methods for the determination of pharmaceuticals in aqueous environmental samples. Trac - Trends Anal. Chem. 2001, 20:419-434.
43. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. J. Chromatogr. A 2008, 1177:150-158.
44. Vanderford B.J., Pearson R.A., Rexing D.J., Snyder S.A. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal. Chem. 2003, 75:6265-6274.
45. Vieno N.M., Harkki H., Tuhkanen T., Kronberg L. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 2007, 41:5077-5084.
46. World Health Organization, 2002. World Health Report. Geneva, 57-58 pp.
47. Yoon Y., Ryu J., Oh J., Choi B.G., Snyder S.A. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci. Total Environ. 2010, 408:636-643.
48. Zhang Y., Geissen S.U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.
49. Zuccato E., Calamari D., Natangelo M., Fanelli R. Presence of therapeutic drugs in the environment. Lancet 2000, 355:1789-1790.
50. Zuccato E., Castiglioni S., Fanelli R., Reitano G., Bagnati R., Chiabrando C., Pomati F., Rossetti C., Calamari D. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ. Sci. Pollut. Res. Int. 2006, 13:15-21.